Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
JPMORGAN CHASE & CO
> AKBA
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Akebia Therapeutics, Inc. | AKBA | 37,903 | -43,644 | 34,681,000 | -10,319,000 | $914.99 |
| 03/31/2023 | Akebia Therapeutics, Inc. | AKBA | 81,547 | 70,156 | 45,000,000 | 44,996,000 | $551.83 |
| 09/30/2022 | Akebia Therapeutics, Inc. | AKBA | 11,391 | 4,171 | 4,000 | 1,000 | $0.35 |
| 06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 7,220 | -4,250,978 | 3,000 | -3,054,000 | $0.42 |
| 03/31/2022 | Akebia Therapeutics, Inc. | AKBA | 4,258,198 | -174,005 | 3,057,000 | -6,960,000 | $0.72 |
| 12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 4,432,203 | -133,532 | 10,017,000 | -3,133,000 | $2.26 |
| 09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 4,565,735 | -382,042 | 13,150,000 | -5,603,000 | $2.88 |
| 06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 4,947,777 | 3,744,760 | 18,753,000 | 14,681,000 | $3.79 |
| 03/31/2021 | Akebia Therapeutics, Inc. | AKBA | 1,203,017 | -255,807 | 4,072,000 | -14,000 | $3.38 |
| 12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 1,458,824 | 1,230,873 | 4,086,000 | 3,542,000 | $2.80 |
| 09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 227,951 | -5,852 | 544,000 | -2,631,000 | $2.39 |
| 06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 233,803 | -246,194 | 3,175,000 | -463,000 | $13.58 |
| 03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 479,997 | 192,907 | 3,638,000 | 1,823,000 | $7.58 |
| 12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 287,090 | -20,300 | 1,815,000 | 609,000 | $6.32 |
| 09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 307,390 | 12,577 | 1,206,000 | -159,000 | $3.92 |
| 06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 294,813 | 14,869 | 1,365,000 | -928,000 | $4.63 |
| 03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 279,944 | -1,384 | 2,293,000 | 738,000 | $8.19 |
| 12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 281,328 | -24,365 | 1,555,000 | -1,144,000 | $5.53 |
| 09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 305,693 | 8,747 | 2,699,000 | -264,000 | $8.83 |
| 06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 296,946 | 25,273 | 2,963,000 | 374,000 | $9.98 |
| 03/31/2018 | Akebia Therapeutics, Inc. | AKBA | 271,673 | -14,584 | 2,589,000 | -1,667,000 | $9.53 |
| 12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 286,257 | 286,257 | 4,256,000 | 4,256,000 | $14.87 |
| 06/30/2017 | Akebia Therapeutics, Inc. | AKBA | 0 | -12,650 | 0 | -117,000 | |
| 03/31/2017 | Akebia Therapeutics, Inc. | AKBA | 12,650 | -42,718 | 117,000 | -459,000 | $9.25 |
| 12/31/2016 | Akebia Therapeutics, Inc. | AKBA | 55,368 | 55,368 | 576,000 | 576,000 | $10.40 |
| 09/30/2016 | Akebia Therapeutics, Inc. | AKBA | 0 | -1,292 | 0 | -10,000 | |
| 06/30/2016 | Akebia Therapeutics, Inc. | AKBA | 1,292 | 1,292 | 10,000 | 10,000 | $7.74 |
| 03/31/2016 | Akebia Therapeutics, Inc. | AKBA | 504 | 504 | 5,000 | 5,000 | $9.92 |
| << Prev Next >> |
|